Impact of activated monocyte and endothelial dysfunction on coagulopathy in Egyptian adult beta thalassemic patients

The mechanism of the well observed hypercoagulability and high incidence of Thromboembolic Events (TE) in β- thalassemia patients has not been fully elucidated. This study aimed to evaluate evaluate the endothelial dysfunction and monocyte activation among adult Egyptian β-thalassemic patients and a...

Full description

Bibliographic Details
Main Authors: Hanaa Abd El-samee, Noha Bassiouny, Nermeen Nabih
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Hematology Reports
Subjects:
Online Access:https://www.pagepress.org/journals/index.php/hr/article/view/8365
_version_ 1797935684939415552
author Hanaa Abd El-samee
Noha Bassiouny
Nermeen Nabih
author_facet Hanaa Abd El-samee
Noha Bassiouny
Nermeen Nabih
author_sort Hanaa Abd El-samee
collection DOAJ
description The mechanism of the well observed hypercoagulability and high incidence of Thromboembolic Events (TE) in β- thalassemia patients has not been fully elucidated. This study aimed to evaluate evaluate the endothelial dysfunction and monocyte activation among adult Egyptian β-thalassemic patients and assess their role in the hypercoagulability and development of TE. A total of 40 adults patients with bthalassemics and 20 healthy age and sex-matched controls were assessed for endothelial dysfunction using serum Von Willebrand Factor Antigen (VWFAg) and for monocytic activation using flow cytometric assessment of CD14 monocyte microparticles and CD11b activated monocytes. The VWF:Ag level was significantly higher among thalassemic patients (P<0.001) and was positively correlated to development of TE (P<0.05). There was no significance difference for CD14 between patients and controls (P>0.5) and CD11b was higher in controls (P=0.004) with no significant correlation between both and TE development (P>0.05). VWF:Ag is increased in thalassemic patients and could be used as a risk factor for thrombosis in these patients, while no identified role of activated monocytes in thrombotic tendency in such patients.
first_indexed 2024-04-10T18:17:59Z
format Article
id doaj.art-6f803a79f25d48a58a29d963dfc976a8
institution Directory Open Access Journal
issn 2038-8322
2038-8330
language English
last_indexed 2024-04-10T18:17:59Z
publishDate 2020-11-01
publisher MDPI AG
record_format Article
series Hematology Reports
spelling doaj.art-6f803a79f25d48a58a29d963dfc976a82023-02-02T08:03:17ZengMDPI AGHematology Reports2038-83222038-83302020-11-0112210.4081/hr.2020.8365Impact of activated monocyte and endothelial dysfunction on coagulopathy in Egyptian adult beta thalassemic patientsHanaa Abd El-samee0Noha Bassiouny1Nermeen Nabih2Department of Internal Medicine, Clinical Hematology Division, Faculty of Medicine, Ain Shams University, CairoDepartment of Clinical Pathology, Faculty of Medicine, Ain Shams University, CairoDepartment of Internal Medicine, Clinical Hematology Division, Faculty of Medicine, Ain Shams University, CairoThe mechanism of the well observed hypercoagulability and high incidence of Thromboembolic Events (TE) in β- thalassemia patients has not been fully elucidated. This study aimed to evaluate evaluate the endothelial dysfunction and monocyte activation among adult Egyptian β-thalassemic patients and assess their role in the hypercoagulability and development of TE. A total of 40 adults patients with bthalassemics and 20 healthy age and sex-matched controls were assessed for endothelial dysfunction using serum Von Willebrand Factor Antigen (VWFAg) and for monocytic activation using flow cytometric assessment of CD14 monocyte microparticles and CD11b activated monocytes. The VWF:Ag level was significantly higher among thalassemic patients (P<0.001) and was positively correlated to development of TE (P<0.05). There was no significance difference for CD14 between patients and controls (P>0.5) and CD11b was higher in controls (P=0.004) with no significant correlation between both and TE development (P>0.05). VWF:Ag is increased in thalassemic patients and could be used as a risk factor for thrombosis in these patients, while no identified role of activated monocytes in thrombotic tendency in such patients.https://www.pagepress.org/journals/index.php/hr/article/view/8365VWFAgCD14CD11bthrombotic eventsβ –thalassemia
spellingShingle Hanaa Abd El-samee
Noha Bassiouny
Nermeen Nabih
Impact of activated monocyte and endothelial dysfunction on coagulopathy in Egyptian adult beta thalassemic patients
Hematology Reports
VWFAg
CD14
CD11b
thrombotic events
β –thalassemia
title Impact of activated monocyte and endothelial dysfunction on coagulopathy in Egyptian adult beta thalassemic patients
title_full Impact of activated monocyte and endothelial dysfunction on coagulopathy in Egyptian adult beta thalassemic patients
title_fullStr Impact of activated monocyte and endothelial dysfunction on coagulopathy in Egyptian adult beta thalassemic patients
title_full_unstemmed Impact of activated monocyte and endothelial dysfunction on coagulopathy in Egyptian adult beta thalassemic patients
title_short Impact of activated monocyte and endothelial dysfunction on coagulopathy in Egyptian adult beta thalassemic patients
title_sort impact of activated monocyte and endothelial dysfunction on coagulopathy in egyptian adult beta thalassemic patients
topic VWFAg
CD14
CD11b
thrombotic events
β –thalassemia
url https://www.pagepress.org/journals/index.php/hr/article/view/8365
work_keys_str_mv AT hanaaabdelsamee impactofactivatedmonocyteandendothelialdysfunctiononcoagulopathyinegyptianadultbetathalassemicpatients
AT nohabassiouny impactofactivatedmonocyteandendothelialdysfunctiononcoagulopathyinegyptianadultbetathalassemicpatients
AT nermeennabih impactofactivatedmonocyteandendothelialdysfunctiononcoagulopathyinegyptianadultbetathalassemicpatients